Article By:
BioMedReports
Tuesday, November 25, 2014 3:27 AM EDT
CPHD announced it has received clearance from the U.S. FDA to market its Xpert®, SUPN, announced the issuance of a fifth patent (number 8,889,191) by the United States Patent and Trademark Office (USPTO), its novel once-daily extended-release topiramate product.